BRIEF published on 10/27/2025 at 17:50, 4 months 29 days ago Eurofins Scientific Reports Weekly Share Buyback Activity Share Repurchase Stock Market Financial Regulation Eurofins Scientific Paris Exchange
PRESS RELEASE published on 10/27/2025 at 17:45, 4 months 29 days ago Acquisition or disposal of the issuer's own shares / Transaction in own shares (aggregate version) Weekly report on share repurchases by Eurofins Scientific SE from 20th to 24th October 2025, totaling 50,000 shares with a weighted average purchase price of 62.4013 Financial Transactions Share Repurchases Eurofins Scientific SE Weekly Report Market Average Price
BRIEF published on 10/21/2025 at 07:20, 5 months 5 days ago Eurofins Records Steady Organic Growth in Nine-Month Period of 2025 Market Expansion Currency Impact 2025 Financial Performance Eurofins Growth Organic Revenue Increase
PRESS RELEASE published on 10/21/2025 at 07:15, 5 months 5 days ago Inside Information / News release on accounts, results Eurofins reports 4.0% organic revenue growth in 9M 2025, with solid full-year outlook. CEO expects margin expansion amidst foreign exchange challenges Financial Performance Organic Revenue Growth Margin Expansion Eurofins FY 2025 Objectives
BRIEF published on 10/09/2025 at 14:01, 5 months 16 days ago Eurofins Scientific Announces Voting Rights and Capital Update Voting Rights Treasury Shares Transparency Regulation Eurofins Scientific Capital Update
PRESS RELEASE published on 10/09/2025 at 13:56, 5 months 16 days ago Total number of voting rights and capital / Information on the total number of voting rights and the number of shares making up the capital Disclosure of total voting rights and capital by EUROFINS SCIENTIFIC SE including origin of change and date. Compliant with 2008 regulation Share Capital Voting Rights Transparency Requirements Eurofins Scientific SE Securities Issuer
BRIEF published on 10/06/2025 at 17:50, 5 months 19 days ago Eurofins Scientific SE Completes Weekly Share Repurchase Share Repurchase XPAR Market Market Regulation Weekly Report Eurofins Scientific
PRESS RELEASE published on 10/06/2025 at 17:45, 5 months 19 days ago Acquisition or disposal of the issuer's own shares / Transaction in own shares (aggregate version) Weekly report on share repurchases by Eurofins Scientific SE from 29th September to 03rd October 2025 Investors Market Abuse Regulation Share Repurchases Eurofins Scientific SE Weekly Report
BRIEF published on 09/02/2025 at 17:54, 6 months 23 days ago Eurofins Completes Strategic Acquisition of Related Party-Owned Sites Corporate Finance Market Expansion Financial Strategy Bioanalytical Testing Eurofins Acquisition
PRESS RELEASE published on 09/02/2025 at 17:49, 6 months 23 days ago Inside Information / Operations of the issuer (acquisitions, sales...) Eurofins completes purchase of related party-owned sites as planned, financed by Euro-denominated bonds. Transaction expected to reduce annualised rent to negligible amounts Purchase Transaction Eurofins Related Party-owned Sites Euro-denominated Bonds
Published on 03/26/2026 at 08:05, 1 hour 15 minutes ago Vanta Announces U.S. Ticker Symbol Change to VNTXF
Published on 03/26/2026 at 04:55, 4 hours 25 minutes ago Vanta Announces Capital Markets Initiatives to Strengthen Financial Position and Support Growth Initiatives
Published on 03/26/2026 at 00:40, 8 hours 40 minutes ago Challenger RC Resource Upgrade Drilling Complete
Published on 03/26/2026 at 00:30, 8 hours 50 minutes ago Nano One Highlights Recent Objectives & Reports Fourth Quarter 2025 Results
Published on 03/25/2026 at 19:15, 14 hours 5 minutes ago Gemina Laboratories Ltd. Announces Delisting from the CSE
Published on 03/26/2026 at 09:05, 14 minutes ago Rockwell Automation Showcases Autonomous Industrial Operations at Hannover Messe 2026
Published on 03/26/2026 at 09:00, 19 minutes ago Original-Research: ZEAL Network SE (von NuWays AG): BUY
Published on 03/26/2026 at 09:00, 19 minutes ago Original-Research: INDUS Holding AG (von NuWays AG): BUY
Published on 03/26/2026 at 07:30, 1 hour 50 minutes ago BIOPHYTIS-LYNXKITE ALLIANCE INVITED TO NVIDIA CONFERENCE: UNLEASHING AI TO REVOLUTIONIZE LONGEVITY
Published on 03/25/2026 at 18:31, 14 hours 49 minutes ago Strong investment performance and active roll-out of our strategy
Published on 03/25/2026 at 17:45, 15 hours 35 minutes ago Combined General Meeting on May 05, 2026: publication of the notice of Meeting
